Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4236 | Virtual Group Intervention Wiki | 1.00 |
| drug4702 | research specific blood sample Wiki | 1.00 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
The purpose of this study is to evaluate different types of exercise programs (virtual group-based exercise program; personal exercise program; wait-list control) across 12-weeks on the physical and mental health of older adults during the current Covid-19 pandemic.
Description: Well-being will be self reported using an 8-item measure from Diener et al., 2010
Measure: Well-Being (Psychological Flourishing) Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: 1-item question by Fleeson, 2004
Measure: Life Satisfaction Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: 1 Item Statistics Canada Stress Question from the Canadian Community Health Survey (2012)
Measure: Stress Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: 10 Item Center for Epidemiologic Studies Depression Scale (CES-D) via Andresen et al., 1994
Measure: Depression Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: 6 item Brief Resilience Scale by Smith et al., 2008
Measure: Resilience Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: items adapted from the 4-item scale by Doosje et al., 1995
Measure: Social Identification Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: 11-item scale by De Jong Gierveld et al., 2006
Measure: Social and Emotional Lonliness Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: question by Charles et al., 2006 adapted from Larsen et al., 1991
Measure: Chronic Illness (Physical Health) Time: Baseline (Week 0)Description: question by Charles et al., 2006 adapted from Marmot et al., 1997
Measure: Weekly Somatic Symptoms (Physical Health) Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: modified version of the Leisure Score Index (LSI; Courneya, Jones, Rhodes, & Blanchard, 2004) that has been applied to Godin's Leisure Time Exercise Questionnaire (GLTEQ; Godin & Shepard, 1985).
Measure: Leisure-time physical activity Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: 3-item measure for alcohol consumption from CDC Behavioral Risk Factor Surveillance System Survey Questionnaire, 1984-2019
Measure: Alcohol Habits Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: Objective measure of attendance in online sessions (interventions conditions only)
Measure: Physical Adherence Time: Looked at each day of the week for 12 weeks to see if a session was attendedDescription: 3 semantic differential items toward physical activity using scale by Azjen, 2006
Measure: Affective Attitudes Time: Baseline (Week 0), Week 2, Week 4, Week 6, Week 8, Week 10, Follow-up (Week 12)Description: Items addressing sex/gender, age, ethnicity, sexual orientation, chronic conditions, smoking behaviour, height, weight, education level, household income level, employment status, marital status, and living situation (i.e., alone vs. others).
Measure: Demographics Time: Baseline only (Week 0)Alphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports